Tags

Type your tag names separated by a space and hit enter

[Use of the artificial endocrine pancreas in the clinic].
Vutr Boles. 1985; 24(6):107-11.VB

Abstract

Via the artificial endocrine pancreas--apparatus "BIOSTATOR" 100 patients were studied and treated, namely: 90 with diabetes mellitus, 7 with hyperinsulinism and 3 with obesity. The 24-h insulin needs of the diabetics with insulin-dependent and non-insulin dependent with secondary exhaustion type of diabetes, were determined. The following subcutaneous insulin dosage was determined, depending on the insulin amount spent during the 24-h biostator control. It was established that the necessary reduction of the intravenously administered insulin is 30% on the average with the passing over to subcutaneous regime. The indices of lipid metabolism were also studied as well as numerous hormones with which the carbohydrate compensation leads to a change. The problem of the "morning" phenomenon is discussed.

Authors

Tsanev A
No affiliation info available
Zlateva S
No affiliation info available
Khristov V
No affiliation info available
Petkova M
No affiliation info available

MeSH

Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic ComaHumansHyperinsulinismInsulin Infusion SystemsObesity

Pub Type(s)

English Abstract
Journal Article

Language

bul

PubMed ID

4095982

Citation

Tsanev, A, et al. "[Use of the Artificial Endocrine Pancreas in the Clinic]." Vutreshni Bolesti, vol. 24, no. 6, 1985, pp. 107-11.
Tsanev A, Zlateva S, Khristov V, et al. [Use of the artificial endocrine pancreas in the clinic]. Vutr Boles. 1985;24(6):107-11.
Tsanev, A., Zlateva, S., Khristov, V., & Petkova, M. (1985). [Use of the artificial endocrine pancreas in the clinic]. Vutreshni Bolesti, 24(6), 107-11.
Tsanev A, et al. [Use of the Artificial Endocrine Pancreas in the Clinic]. Vutr Boles. 1985;24(6):107-11. PubMed PMID: 4095982.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Use of the artificial endocrine pancreas in the clinic]. AU - Tsanev,A, AU - Zlateva,S, AU - Khristov,V, AU - Petkova,M, PY - 1985/1/1/pubmed PY - 1985/1/1/medline PY - 1985/1/1/entrez SP - 107 EP - 11 JF - Vutreshni bolesti JO - Vutr Boles VL - 24 IS - 6 N2 - Via the artificial endocrine pancreas--apparatus "BIOSTATOR" 100 patients were studied and treated, namely: 90 with diabetes mellitus, 7 with hyperinsulinism and 3 with obesity. The 24-h insulin needs of the diabetics with insulin-dependent and non-insulin dependent with secondary exhaustion type of diabetes, were determined. The following subcutaneous insulin dosage was determined, depending on the insulin amount spent during the 24-h biostator control. It was established that the necessary reduction of the intravenously administered insulin is 30% on the average with the passing over to subcutaneous regime. The indices of lipid metabolism were also studied as well as numerous hormones with which the carbohydrate compensation leads to a change. The problem of the "morning" phenomenon is discussed. SN - 0506-2772 UR - https://www.unboundmedicine.com/medline/citation/4095982/[Use_of_the_artificial_endocrine_pancreas_in_the_clinic]_ DB - PRIME DP - Unbound Medicine ER -